Industries > Pharma > Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

In-depth Analysis of Top 50 Pharma CMOs: Capabilities, Results, Competition and Sales Potentials

PUBLISHED: 06 January 2021
PAGES: 395
PRODUCT CODE: PHA1026
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA1026 Categories: , Tags: , , ,

Are you in the global race? Where do you stand in the cut throat global competition?
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

Buy this report to find out an analysis of strategies adopted by Top 50 players in the market to stay ahead of their competitor.

Contract manufacturing and outsourcing in the form of pay for services or strategic collaboration has resulted in the development of a new paradigm that offers new opportunities to companies for improving their bottom lines through the conversion of fixed costs to variable costs. Contract manufacturers that perform custom synthesis and produce intermediates, active pharmaceutical ingredients and dosage forms are becoming increasingly important for the drug developers to conduct their business more efficiently. Rapid economic growth in the emerging markets is also advancing the pharmaceutical/biopharmaceutical contract manufacturing market. Cost, once considered the only reason for outsourcing, is now accomplished by quality and reliability.

To access the data contained in this document please email contactus@visiongain.com

How this report will benefit you?
The 395-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the global top 50 rankings, top business strategies adopted by the key players, product mapping, services provided, recent activities of the companies, key drivers and challenges affecting the market.

Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 434-page report you will receive 400+ tables and 300+ figures– all unavailable elsewhere.

Market Insights
Boots Contract Manufacturing, a unit of Wallgreen Boots Alliance Inc., was the leader in the non-sterile liquid contract manufacturing market with a xx% share. Catalent Pharma Solutions had a 6.8% share, and GlaxoSmithKline (GSK) and Perrigo Company PLC also had notable shares in this market. Mylan N.V., Lyne Laboratories and Wockhardt Ltd. are other contributors in the non-sterile liquid dosage form market via contract manufacturing. Many renowned pharmaceutical companies such as Boehringer Ingelheim, AbbVie Inc., Dr. Reddy’s, Pharmaceutical International GmbH and Jubilant Lifesciences also contributed to this market, holding a 69.3% cumulative market share.

COVID-19 Impact on Pharmaceutical Contract Manufacturing Market
Due to the recent outbreak of COVID-19, the changing delivery chain scenario is likely to have a prominent effect in the short term on global contract manufacturing, including China. The demand for large-scale contract manufacturing is expected to increase significantly as pharmaceutical companies start full-scale operations following the coronavirus outbreak. After the end of the COVID-19 pandemic, several organizations will seek to increase their productivity to meet the growing demand. This means that such larger companies should appoint contract development and manufacturing organizations to deal with losses suffered during the crisis. In addition, numerous governmental bodies develop innovative plans to boost contract development and producing organizations to boost productivity for other bigger organizations.

By ordering and reading our brand-new report today you stay better informed and ready to act. Visiongain’s study is intended for anyone requiring commercial analyses for the top 50 pharmaceutical contract manufacturing market. You find data, trends and predictions.

Companies Profiled in the Report
• AbbVie Inc Company
• Aenova Group Company
• Ajinomoto Bio-Pharma Services Company
• Alcami Corporation Company
• Alkermes Biotechnology company
• Almac Group Company
• Aurobindo Pharma Ltd.
• Avid Bioservices Inc.
• Baxter Biopharma Solutions Company
• Bayer AG Company
• Biocon Limited Company
• Biomay AG Company
• Biophore India Pharmaceuticals Private Limited Company
• Bora Pharmaceuticals Company
• C.H. Boehringer Sohn AG & Ko. KG Company
• Cambrex Corporation Company
• Cardinal Health, Inc. Company
• Catalent Pharma Solutions Inc.
• Cepia Sanofi Company (Parental of Sanofi)
• Charles River Laboratories International, Inc. Company
• Consort Medical plc
• Corden Pharma International Company
• Daito Pharmaceutical Co., Ltd. Company
• Delpharm SAS Company
• Divi’s Laboratories Ltd
• DPT Laboratories, Ltd. (Mylan N.V.) Company
• Dr. Reddy’s Laboratories Company
• Evonik Degussa Company
• F. Hoffmann-La Roche Ltd
• Famar S.A. Company
• Fareva Pharmaceuticals Company
• Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
• GlaxoSmithKline Pharmaceutical Company
• Huapont Life Sciences Co Ltd Company
• Koninklijke DSM N.V. (Royal DSM) Company
• Lonza AG Company
• Nipro Corporation
• Pfizer Company
• Recipharm AB Company
• SAFC Biosciences (Merck KGaA Subsidiaries) Company
• Samsung Biologics Company
• Siegfried Holding Company
• Strides Pharma Science Limited Company
• Teva Pharmaceuticals Company
• Therapure Biopharma, Inc. Company
• Thermo Fisher Scientific Inc.
• UPM Pharmaceuticals Company
• Vetter Pharma Company
• WuXi AppTec Company
• Zhejiang Hisun Pharmaceutical Company

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021: In-depth Analysis of Top 50 Pharma CMOs: Capabilities, Results, Competition and Sales Potentials. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories